Cart
sales@molnova.com
Carboxylesterase-IN-2
CAS No. 2764748-88-9
Carboxylesterase-IN-2( —— )
Catalog No. M36936 CAS No. 2764748-88-9
Carboxylesterase-IN-2 is a potent Carboxylesterase Notum inhibitor (IC50 <= 10 nM).Carboxylesterase-IN-2 has potential for the study of cancer diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 141 | In Stock |
|
| 5MG | 227 | In Stock |
|
| 10MG | 359 | In Stock |
|
| 25MG | 596 | In Stock |
|
| 50MG | 821 | In Stock |
|
| 100MG | 1107 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarboxylesterase-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarboxylesterase-IN-2 is a potent Carboxylesterase Notum inhibitor (IC50 <= 10 nM).Carboxylesterase-IN-2 has potential for the study of cancer diseases.
-
DescriptionCarboxylesterase-IN-2 (compound 4u) is a potent inhibitor of Carboxylesterase Notum with an IC50 less than or equal to 10 nM. Notum is a negative regulator of Wnt signaling acting through the hydrolysis of a palmitoleoylate ester, which is required for Wnt activity. Carboxylesterase-IN-2 has the potential for the research of cancer disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin | Lipid
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2764748-88-9
-
Formula Weight272.33
-
Molecular FormulaC13H12N4OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (183.60 mM; Ultrasonic )
-
SMILESO=C1N2C(C=CC(SC3=CC(C)=C(C)C=C3)=N2)=NN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Steadman D, et al. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity. J Med Chem. 2022;65(1):562-578.?
molnova catalog
related products
-
Wnt pathway activato...
Wnt pathway activator 1 is a potent Wnt activator with an IC50 of 28-29 nM. Wnt pathway activator 1 is a potent Wnt activator for the treatment of androgenetic alopecia (AGA) extracted from patent WO2012024404A1.
-
PRI-724 B
PRI-724 is a second-generation, selective small molecule inhibitor of the β-catenin/CBP interaction.
-
Ipafricept
Ipafricept (OMP-54F28) is a recombinant fusion protein consisting of the extracellular portion of the human frizzled-8 receptor fused to a fragment of human IgG1 Fc, and a Wnt inhibitor that blocks Wnt signaling.
